Process development of an acellular dermal matrix (ADM) for biomedical applications
Source abstract
Abstract
The object of this study was to compare the extent of decellularization at each critical step of processing porcine skin to produce an acellular dermal matrix (ADM) for biomedical applications. The results demonstrated that the removal of epidermis using treatment with 0.25% trypsin for 18 h and 0.1% sodium dodecyl sulfate (SDS) for 12 h at room temperature was beneficial for the subsequent treatment to remove cells in the dermal structure. Lengthy incubation in 0.25% trypsin (12 h) and then 560 units/l Dispase (12 h) at 25 degrees C of small pieces of porcine skin from which the epidermis had been removed efficiently removed cells and cellular components from the skin. Histological examinations revealed that the epidermis, dermal fibroblasts, and epidermal appendages were completely removed by these treatments, and the basic dermal architecture of collagen bundles was that of a loose meshwork. Examinations by TEM showed that the characteristics of collagen fibers in the ADM were retained after complete removal of cells present under optimal conditions defined in this study. SDS-PAGE and size-exclusion HPLC revealed that collagen fibers in the ADM were mostly type I and showed two typical component peaks identified as oligomers and monomers, respectively.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Wound Healing and Treatments · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (12)
Show source-provided references
1. Use of an acellular allograft dermal matrix (Alloderm) in the management of full-thickness burns10.1016/0305-4179(95)93866-I ↗
2. Use of an acellular dermal allograft for dural replacement10.1097/00006123-199908000-00025 ↗
3. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation10.1001/archfaci.2.2.130 ↗
4. Use of porcine acellular dermal matrix as a dermal substitute in rates10.1097/00000658-200103000-00015 ↗
5. Evaluation of the porcine intestinal collagen layer as a biomaterial10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.0.CO;2-4 ↗
6. Characterization of acellular dermal matrices (ADMs) prepared by two different methods10.1016/S0305-4179(97)00110-1 ↗
7. Transplanted acellular allograft dermal matrix. Potential for the reconstruction of viable dermis10.1097/00007890-199507150-00001 ↗
8. Dispase/detergent treated dermal matrix as a dermal substitute10.1016/0305-4179(95)00123-9 ↗
9. Acellular allogenic dermal matrix as a dermal substitute
10. Lee Y, Chen MY, Kuo CY, Chang HC. Preparation of porcine dermal matrix graft. Global Chinese Symposium on Biomaterials and Controlled Release; 1999. p. 584–7.
11. Badylak SF, Matheny R, Obermiller J, Geddes LA. ECM scaffold for myocardial reconstruction. Symposium on Tissue Engineering Science. Aegean Conferences Series, vol. 4, 2002. p. 65.
12. Badylak SF, Ling F, Record R, Hodde J. Vascularization of 3-dimensional scaffolds. Symposium on Tissue Engineering Science. Aegean Conferences Series, vol. 4, 2002. p. 63.